Recent Company News

• 04:06 PM ET Jun 12, 2026
  

  Inventiva completes steps of transactions previously announced on 2-Jun-26 (€3.42, 0.00)

• 04:16 AM ET Jun 05, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:42 AM ET Jun 05, 2026
  

  StreetAccount Summary - EU equity offerings recap, week of 1-Jun

• 06:23 PM ET Jun 03, 2026
  

  Transcript Intelligence: Inventiva at Jefferies Global Healthcare Conference

• 06:11 AM ET Jun 03, 2026
  

  Inventiva's offering of 27.3M new ADSs at $4.40/ADS through Leerink Partners, Stifel, Nicolaus & Co and Stifel Europe is expected to close on 5-Jun - 6-K (€3.26, -0.17)

• 08:33 AM ET Jun 02, 2026
  

  Inventiva announces a comprehensive capital structure optimization including debt and equity financing in advance of the anticipated phase 3 readout (€4.19, 0.00)

• 06:15 AM ET Jun 02, 2026
  

  Inventiva files shelf (ordinary shares, ADS and warrants) of indeterminate amount - F-3ASR (€4.19, 0.00)

• 01:34 AM ET Jun 02, 2026
  

  Inventiva announces temporary trading halt of its shares on Euronext Paris ahead of a proposed financing transaction (€4.19, 0.00)

• 04:03 PM ET May 26, 2026
  

  Inventiva reports Q1 cash and cash equivalents at €75.0M (€4.55, 0.00)

• 04:03 PM ET Apr 22, 2026
  

  Inventiva names Axel-Sven Malkomes CFO among leadership appointments ahead of expected phase 3 data readout of Lanifibranor (€4.56, 0.00)